In May, PhD students who are funded by the Medical Research Council (MRC) were invited to enter the Max Perutz science writing award 2020 and to tell the general public why your research matters. From the many entries received, the 10 that made the shortlist covered diverse topics, including motor neurone disease, self-harm, babies experiences of pain, and bone loss resulting from space travel.
The essays were judged by the Observers Ian Tucker, the Science Museums Roger Highfield, Prof Fiona Watt from the MRC, Bristol Universitys Andy Ridgeway and the journalist and broadcaster Samira Ahmed.
At a virtual ceremony last Tuesday, the 1,500 prize was presented to the winner, Sarah Taylor from the MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh for her article about her research into the influence of proteins on the effectiveness of chemotherapy.
Here we publish the winning article, described by Samira Ahmed as a terrifically told and intriguing story.
She sits in the small consulting room once again, waiting to hear the news of her latest scan. It has been a difficult journey since the last time she sat in this chair, before her most recent round of treatment began. Over a month of exhaustion, vomiting, soreness, sleepless nights and the inevitable hair loss. But this time, the chemotherapy has not been successful. After all the side effects, all the pain that she has endured, her tumour is still growing, a dark mass on her ovary. Where does she go from here? What can she do when the treatment shes pinned all her hopes on just stops working?
This situation is all too common for women with high grade serous ovarian cancer (HGSOC), a devastating form of ovarian cancer. Only 35% survive longer than five years following their diagnosis. While chemotherapy and surgery are highly effective at initially shrinking tumours, the cancer continues to fight back. Over time the tumour changes, with cells that survive treatment prevailing and replicating, passing on the protective traits that give them that survival edge. The tumour becomes completely resistant to chemotherapy, and no barrier remains to stop it from growing out of control and overwhelming the body.
However, there are groups of patients whose cancers are much more sensitive to chemotherapy treatment than others, who can be completely cured by chemotherapy. One key to this is DNA repair proteins, the tools that all cells use to protect their DNA from damage. Think of this DNA as the instruction manual for a cell, detailing how to build all the proteins the cell requires to live and carry out different functions. Cancer cells often have defective DNA repair proteins, as this allows them to adapt and grow rapidly. Strange as it may sound, this can be a good thing from our perspective! Chemotherapy kills cancer cells by attacking their DNA, and those which lack DNA repair proteins essentially forgot to bring a first aid kit they cannot fix themselves up and keep going. This means that the chemotherapy can completely kill off the cancer, so the patient will survive. This reveals gaps in the armour of this cancer, which we can exploit to help the women who need it most.
No two cancers are quite the same, even within a specific type like HGSOC. Some have completely functional DNA repair proteins. Some have defective proteins initially but can adapt and fix these. Others can make excessive amounts of the proteins to combat the effects of chemotherapy and survive. I hope that by learning what happens to these proteins as a cancer cell becomes resistant to chemotherapy, I can make new drugs to prevent the crucial DNA repair proteins from functioning, which will enable the chemotherapy to kill cancer cells more effectively.
The first question that I asked was which, if any, of these proteins are actually important for the way HGSOC reacts to chemotherapy. I used cells taken from HGSOC patient tumours and adapted to grow easily in the lab, called cell lines, which have similar properties to an actual tumour in a patient. By using cell lines taken from a selection of patient tumours, scientists can build up a picture of the similarities and differences between patient tumours. I started by assessing the growth of various cell lines when treated with a drug called carboplatin, the standard chemotherapy used to treat HGSOC. The slower the cells grow, the more effective it is as a treatment. I found that there was a lot of variation in sensitivity to carboplatin between the different cell lines unsurprising really since one of the main challenges in cancer research is how many differences there are between individuals tumours, and even between different parts of the same tumour.
Next, I set out to find the reason for these differences, looking for changes in the DNA repair proteins. I studied a database of ovarian cancer patients looking for clues on what could be going on, and found that it is common for the tumour cells to produce either abnormally high or low amounts of certain DNA repair proteins. So, I decided to measure the amount of repair proteins produced by my cell lines. I found that in the cell line that was most sensitive to chemotherapy, one of these repair proteins was almost entirely missing! This is a really good indicator that this protein could be an important factor behind repairing the damage caused by chemotherapy.
So, I had identified a protein potentially involved in chemotherapy effectiveness. What next? I wanted to confirm that this protein acts in the way I suspected within the cancer cells. I blocked the cell lines from producing the protein I was interested in, and again looked to see how sensitive to chemotherapy the cancer cells were. This confirmed my initial suspicions removing the protein made the cancer cells much more susceptible to chemotherapy!
As I am only in my first year of working on this project, there is still much to be done, but this is an exciting starting point. I certainly find it very exciting! I plan to study the mechanism used by these cancer cells to alter the amount of this repair protein, and see how smart the cancer cells are are they cheating the chemotherapy by producing more of this protein to prevent the cells from being killed? Does this result in a chemotherapy-resistant tumour? Most importantly, I would like to identify patients whose cancers have high levels of this repair protein, for whom conventional chemotherapy might be less effective, and focus on how I can help them. To tackle this problem, I would like to test drugs that block this protein from carrying out DNA damage repair, leaving the cancer powerless, unable to repair the damage inflicted by chemotherapy. My dream is that one day this will help more women to leave that consulting room feeling victorious, having beaten the odds, and able to shut the door for good on their way out.
Here is the original post:
Curing the incurable: teaching an old drug new tricks to fight ovarian cancer - The Guardian
- Podcast 9 Athens part 3 and news - November 8th, 2009 [November 8th, 2009]
- Podcast 10 Athens part 4 - November 8th, 2009 [November 8th, 2009]
- Podcast 11 Athens Part 5 - November 8th, 2009 [November 8th, 2009]
- Episode 12 Cardiac Nuclear Medicine in the UK - November 8th, 2009 [November 8th, 2009]
- Podcast 13 Choline PET and prostate cancer - November 8th, 2009 [November 8th, 2009]
- Episode14 ED function and Dysponea - November 8th, 2009 [November 8th, 2009]
- ep 15 Collimator Choice and Reconstruction algorithm - November 8th, 2009 [November 8th, 2009]
- Episode 16 Dr Strauss on vulnerable plaque - November 8th, 2009 [November 8th, 2009]
- Episode17 Chemical Stress - November 8th, 2009 [November 8th, 2009]
- Episode 18 Myocardial Perfusion Imaging and Diabetes - November 8th, 2009 [November 8th, 2009]
- Episode 19 The INSPIRE trial - November 8th, 2009 [November 8th, 2009]
- 20 Dual isotope with a difference - November 8th, 2009 [November 8th, 2009]
- Episode 21 The real effect of stress - November 8th, 2009 [November 8th, 2009]
- Episode 22 D-SPECT - November 8th, 2009 [November 8th, 2009]
- Episode 23 VQ Reprise - November 8th, 2009 [November 8th, 2009]
- Episode 24 Hepatobiliary Nuclear Medicine - November 8th, 2009 [November 8th, 2009]
- Episode 25 Sleep Apnea - November 8th, 2009 [November 8th, 2009]
- Episode 26 Imaging Post Traumatic Stress Disorder - November 8th, 2009 [November 8th, 2009]
- Episode 27 Cardiac Stem Cells - November 8th, 2009 [November 8th, 2009]
- Episode 28 Molly Supply - November 8th, 2009 [November 8th, 2009]
- Episode 29 Melanoma therapy interview with Dr Ekaterina Dadachova - November 8th, 2009 [November 8th, 2009]
- Episode 30 Viral Therapy - November 8th, 2009 [November 8th, 2009]
- Episode 31 breast radiotherapy using radioisotopes - November 8th, 2009 [November 8th, 2009]
- Episode 32 news from snm - November 8th, 2009 [November 8th, 2009]
- Episode 33 EBV Imaging and Therapy - November 8th, 2009 [November 8th, 2009]
- Episode 34 Dr Lele SNM India 2009 - December 14th, 2009 [December 14th, 2009]
- Episode 35 Dr Andrew Scott from the Ludwig institute - January 10th, 2010 [January 10th, 2010]
- Episode 36 CardiArc - February 25th, 2010 [February 25th, 2010]
- Episode 37 Dr Modder Radiosynoviorthesis (Radiation Synovectomy) - March 31st, 2010 [March 31st, 2010]
- Episode 38 Indian Nuclear Medicine With Dr Malhotra and Dr Krishna - May 28th, 2010 [May 28th, 2010]
- Episode 39 Prof Ora Israel The Utility of Hybrid Imaging - July 13th, 2010 [July 13th, 2010]
- Episode 40 New V/Q SPECT developments - October 11th, 2010 [October 11th, 2010]
- Episode 41 scintimun - February 14th, 2011 [February 14th, 2011]
- Episode 42 Radio-Isotope Supply into the future - March 6th, 2011 [March 6th, 2011]
- Podcast 4: DNA therapy - April 24th, 2011 [April 24th, 2011]
- Sorry about the delay a new podcast will be out soon! - April 24th, 2011 [April 24th, 2011]
- Podcast 5 Flash 3D - April 24th, 2011 [April 24th, 2011]
- Podcast 6 Affibody - April 24th, 2011 [April 24th, 2011]
- Podcast 7 EANM 2006 Athens Part 1 - April 24th, 2011 [April 24th, 2011]
- Podcast 8 Athens Part 2 - April 24th, 2011 [April 24th, 2011]
- Episode 43 Rapidscan Part 1, 720P high quality video version - May 1st, 2011 [May 1st, 2011]
- Episode 43 Rapidscan Part 1, Ipod quality video - May 1st, 2011 [May 1st, 2011]
- Episode 43 Rapidscan Part 1, Audio version - May 1st, 2011 [May 1st, 2011]
- Episode 45 Mummies with cardiovascular disease video - May 21st, 2011 [May 21st, 2011]
- Episode 45 Mummies with cardiovascular disease audio edition - May 21st, 2011 [May 21st, 2011]
- Episode 46 Dr Gordon DePuey Choosing Reconstruction clinical perspective - August 7th, 2011 [August 7th, 2011]
- Episode 46 Dr Gordon DePuey Choosing Reconstruction clinical perspective audio version - August 7th, 2011 [August 7th, 2011]
- Episode 47 Cardiac Image Fusion With Dr Kaufmann - September 18th, 2011 [September 18th, 2011]
- Episode 47 Cardiac Fusion with Dr Kaufmann video version - September 18th, 2011 [September 18th, 2011]
- Dear Steve, I am and many more like me are your one more thing. - October 9th, 2011 [October 9th, 2011]
- EPISODE 48 PET MRI camera from Siemens with Dr Georgi audio - October 23rd, 2011 [October 23rd, 2011]
- EPISODE 48 PET MRI camera from Siemens Dr Georgi video - October 23rd, 2011 [October 23rd, 2011]
- Silicon Biosystems to Present Single-Circulating Tumor Cell Molecular Characterization at the Fourth World CTC Summit - April 25th, 2012 [April 25th, 2012]
- Leukaemia cells have a remembrance of things past - April 25th, 2012 [April 25th, 2012]
- Technologist Education Requirements Can Help Cut Repeat Scans - April 25th, 2012 [April 25th, 2012]
- HKU Collaborative Research Discovers A Novel Molecular Mechanism Of A New Anti-HIV-1 Drug Candidate - April 25th, 2012 [April 25th, 2012]
- Focal Segmental Glomerulosclerosis and the Nephrotic Syndrome - Part 1 Clinical - Video - May 4th, 2012 [May 4th, 2012]
- Electro-Medicine : Biological Physics - The Molecular Basis of Alzheimers Disease - Video - May 4th, 2012 [May 4th, 2012]
- osdd heterocyclic compounds and molecular medicines - Video - May 4th, 2012 [May 4th, 2012]
- Molecule to Medicine: The Biomarker Frontier - Video - May 4th, 2012 [May 4th, 2012]
- Fulfilling the Promise of Molecular Medicine in a Developmental Brain Disorder - Video - May 4th, 2012 [May 4th, 2012]
- Focus on Stefanie Dimmeler - Video - May 4th, 2012 [May 4th, 2012]
- Dundee - May 4th, 2012 [May 4th, 2012]
- Nanotechnology In Medicine: Huge Potential, But What Are The Risks? - May 5th, 2012 [May 5th, 2012]
- Cutting Edge Technology Coming To DMH - May 5th, 2012 [May 5th, 2012]
- This Week in Experimental and Molecular Pathology - May 5th, 2012 [May 5th, 2012]
- Researchers' discovery offers hope for cancer, heart disease miracle drugs - May 7th, 2012 [May 7th, 2012]
- Penn State student Zachary Hostetler from Garnet Valley is being honored as a student marshal - May 7th, 2012 [May 7th, 2012]
- NCKU Student Wins Prestigious Award for Anti-Cancer Research - May 10th, 2012 [May 10th, 2012]
- In-Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers ... - May 10th, 2012 [May 10th, 2012]
- Pitt team uses genomics to identify a molecular-based treatment for a viral skin cancer - May 10th, 2012 [May 10th, 2012]
- Genomics used to identify a molecular-based treatment for a viral skin cancer - May 10th, 2012 [May 10th, 2012]
- 2 molecular biologists get $500K medical prize - May 13th, 2012 [May 13th, 2012]
- 2 molecular biologists share $500K medical prize - May 13th, 2012 [May 13th, 2012]
- Lab21 Unveils New Molecular Analysis Services at Greenville Site - May 13th, 2012 [May 13th, 2012]
- 2 molecular biologists from NYC to share $500K medical prize for pioneering research on cells - May 13th, 2012 [May 13th, 2012]
- Two Molecular Biologists Get $500K Medical Prize - May 13th, 2012 [May 13th, 2012]
- Pair of molecular biologists receive Albany Medical Center Prize - May 13th, 2012 [May 13th, 2012]
- CNIO scientists successfully test the first gene therapy against aging-associated decline - May 16th, 2012 [May 16th, 2012]
- Cancer Institute of New Jersey Aims to Advance Personalized Cancer Treatments Through 'Precision Medicine' - May 16th, 2012 [May 16th, 2012]